Literature DB >> 11149939

Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival.

M F Princiotta1, U Schubert, W Chen, J R Bennink, J Myung, C M Crews, J W Yewdell.   

Abstract

The proteasome is the primary protease used by cells for degrading proteins and generating peptide ligands for class I molecules of the major histocompatibility complex. Based on the properties of cells adapted to grow in the presence of the proteasome inhibitor 4-hydroxy-5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone (NLVS), it was proposed that proteasomes can be replaced by alternative proteolytic systems, particularly a large proteolytic complex with a tripeptidyl peptidase II activity. Here we show that NLVS-adapted cells retain sensitivity to a number of highly specific proteasome inhibitors with regard to antigenic peptide generation, accumulation of polyubiquitinated proteins, degradation of p53, and cell viability. In addition, we show that in the same assays (with a single minor exception), NLVS-adapted cells are about as sensitive as nonselected cells to Ala-Ala-Phe-chloromethylketone, a specific inhibitor of tripeptidyl peptidase II activity. Based on these findings, we conclude that proteasomes still have essential proteolytic functions in adapted cells that are not replaced by Ala-Ala-Phe-chloromethylketone-sensitive proteases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11149939      PMCID: PMC14618          DOI: 10.1073/pnas.98.2.513

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  The proteasome: paradigm of a self-compartmentalizing protease.

Authors:  W Baumeister; J Walz; F Zühl; E Seemüller
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

Review 2.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?

Authors:  J W Yewdell; L C Antón; J R Bennink
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

3.  The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.

Authors:  V Cerundolo; A Benham; V Braud; S Mukherjee; K Gould; B Macino; J Neefjes; A Townsend
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

4.  Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors.

Authors:  M Bogyo; J S McMaster; M Gaczynska; D Tortorella; A L Goldberg; H Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.

Authors:  A Craiu; M Gaczynska; T Akopian; C F Gramm; G Fenteany; A L Goldberg; K L Rock
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

6.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

7.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.

Authors:  L Meng; R Mohan; B H Kwok; M Elofsson; N Sin; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

8.  Active site-directed inhibitors of Rhodococcus 20 S proteasome. Kinetics and mechanism.

Authors:  T Mc Cormack; W Baumeister; L Grenier; C Moomaw; L Plamondon; B Pramanik; C Slaughter; F Soucy; R Stein; F Zühl; L Dick
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

9.  Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins.

Authors:  M Fujimuro; H Sawada; H Yokosawa
Journal:  FEBS Lett       Date:  1994-08-01       Impact factor: 4.124

10.  Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival.

Authors:  W Heinemeyer; J A Kleinschmidt; J Saidowsky; C Escher; D H Wolf
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

View more
  18 in total

1.  A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Authors:  John T Hunzeker; Michael D Elftman; Jennifer C Mellinger; Michael F Princiotta; Robert H Bonneau; Mary E Truckenmiller; Christopher C Norbury
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

2.  Molecular architecture and assembly mechanism of Drosophila tripeptidyl peptidase II.

Authors:  Beate Rockel; Jürgen Peters; Shirley A Müller; Gönül Seyit; Philippe Ringler; Reiner Hegerl; Robert M Glaeser; Wolfgang Baumeister
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

3.  Production of an antigenic peptide by insulin-degrading enzyme.

Authors:  Nicolas Parmentier; Vincent Stroobant; Didier Colau; Philippe de Diesbach; Sandra Morel; Jacques Chapiro; Peter van Endert; Benoît J Van den Eynde
Journal:  Nat Immunol       Date:  2010-04-04       Impact factor: 25.606

4.  Tripeptidyl Peptidase II Is Required for c-MYC-Induced Centriole Overduplication and a Novel Therapeutic Target in c-MYC-Associated Neoplasms.

Authors:  Stefan Duensing; Sebastian Darr; Rolando Cuevas; Nadja Melquiot; Anthony G Brickner; Anette Duensing; Karl Münger
Journal:  Genes Cancer       Date:  2010-09

5.  Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands.

Authors:  Jiajie Wei; Damien Zanker; Anthony R Di Carluccio; Margery G Smelkinson; Kazuyo Takeda; Mina O Seedhom; Devin Dersh; James S Gibbs; Ning Yang; Ajit Jadhav; Weisan Chen; Jonathan W Yewdell
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 6.  Proteases in MHC class I presentation and cross-presentation.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Lianjun Shen
Journal:  J Immunol       Date:  2010-01-01       Impact factor: 5.422

7.  Tripeptidyl peptidase II. An oligomeric protease complex from Arabidopsis.

Authors:  Adam J Book; Peizhen Yang; Mark Scalf; Lloyd M Smith; Richard D Vierstra
Journal:  Plant Physiol       Date:  2005-05-20       Impact factor: 8.340

8.  Equine infectious anemia virus and the ubiquitin-proteasome system.

Authors:  David E Ott; Lori V Coren; Raymond C Sowder; Julian Adams; Kunio Nagashima; Ulrich Schubert
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.

Authors:  Masahiro Kawahara; Ian A York; Arron Hearn; Diego Farfan; Kenneth L Rock
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

10.  Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.

Authors:  Carsten Berges; Heinrich Haberstock; Dominik Fuchs; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel; Cord Naujokat
Journal:  Immunology       Date:  2008-01-23       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.